Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Cryosite Limited ( (AU:CTE) ) has shared an announcement.
Cryosite Limited has launched a new interactive Investor Hub aimed at enhancing communication with shareholders, stakeholders, and potential investors. This platform is designed to foster direct engagement with the company’s leadership, allowing users to ask questions, provide feedback on ASX announcements, and participate in discussions, thereby strengthening Cryosite’s investor relations and transparency.
More about Cryosite Limited
Cryosite is an Australian company specializing in outsourced clinical trials depot services. Established in 2000, it offers expertise in clinical trial logistics, managing temperature-sensitive products with a team of highly qualified scientists ensuring efficiency and safety. The company’s services include importation, storage, distribution, and reverse logistics, focusing on professional, reliable, and compliant operations.
YTD Price Performance: -8.24%
Average Trading Volume: 31,402
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$38.07M
Find detailed analytics on CTE stock on TipRanks’ Stock Analysis page.
